MedTrace Logo

Retrospective Evaluation of CroFab - Efficacy in Severe Envenomation

NCT00927381 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 247

Last updated 2022-06-28

No results posted yet for this study

Summary

Retrospective observational review of severe envenomation treatment with CroFab

Conditions

  • Snake Envenomation

Sponsors & Collaborators

  • BTG International Inc.

    lead OTHER

Principal Investigators

  • Richard C Dart, MD, PhD · Rocky Mountain Poison and Drug Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2005-01-31
Completion
2005-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00927381 on ClinicalTrials.gov